All Stories

  1. Comparison of Mid and Near-Infrared Spectroscopy to Predict Creatinine, Urea and Albumin in Serum Samples as Biomarkers of Renal Function
  2. Rapid FTIR Spectral Fingerprinting of Kidney Allograft Perfusion Fluids Distinguishes DCD from DBD Donors: A Pilot Machine Learning Study
  3. Multiplex Targeted Proteomic Analysis of Cytokine Ratios for ICU Mortality in Severe COVID-19
  4. Analyzing Heart Rate Variability for COVID-19 ICU Mortality Prediction Using Continuous Signal Processing Techniques
  5. Predictive Models of Patient Severity in Intensive Care Units Based on Serum Cytokine Profiles: Advancing Rapid Analysis
  6. Cytokine-Based Insights into Bloodstream Infections and Bacterial Gram Typing in ICU COVID-19 Patients
  7. Integration of FTIR Spectroscopy and Machine Learning for Kidney Allograft Rejection: A Complementary Diagnostic Tool
  8. Chitosan Nanoparticles for Enhanced Immune Response and Delivery of Multi-Epitope Helicobacter pylori Vaccines in a BALB/c Mouse Model
  9. Comparison of two metabolomics-platforms to discover biomarkers in critically ill patients from serum analysis
  10. Early Mortality Prediction in Intensive Care Unit Patients Based on Serum Metabolomic Fingerprint
  11. Analysis of six consecutive waves of ICU-admitted COVID-19 patients: key findings and insights from a Portuguese population
  12. Impact of neutrophil‐activating protein conservation on diagnostic tests and vaccine design
  13. Discovery of Delirium Biomarkers through Minimally Invasive Serum Molecular Fingerprinting
  14. A new methodology for a rapid and high‐throughput comparison of molecular profiles and biological activity of phytoextracts
  15. Bridging the gap between target-based and phenotypic-based drug discovery
  16. Enhancing Bioactive Compound Classification through the Synergy of Fourier-Transform Infrared Spectroscopy and Advanced Machine Learning Methods
  17. Simplifying Data Analysis in Biomedical Research: An Automated, User-Friendly Tool
  18. Enhancing Bioactive Compound Classification through the Synergy of Fourier-Transform Infrared Spectroscopy and Advanced Machine Learning Methods
  19. Predicting Cellular Rejection of Renal Allograft Based on the Serum Proteomic Fingerprint
  20. Exosomes and microvesicles in kidney transplantation: the long road from trash to gold
  21. The Characteristics and Laboratory Findings of SARS-CoV-2 Infected Patients during the First Three COVID-19 Waves in Portugal—A Retrospective Single-Center Study
  22. Blood molecular profile to predict genotoxicity from exposure to antineoplastic drugs
  23. A new methodology for a rapid and high-throughput comparison of molecular profiles and biological activity of phytoextracts
  24. Alternative Serum Biomarkers of Bacteraemia for Intensive Care Unit Patients
  25. Comparison of Analytical Methods Of Serum Untargeted Metabolomics
  26. The Impact of the Serum Extraction Protocol on Metabolomic Profiling Using UPLC-MS/MS and FTIR Spectroscopy
  27. Label-free discrimination of T and B lymphocyte activation based on vibrational spectroscopy – A machine learning approach
  28. Quality Monitoring of Biodiesel and Diesel/Biodiesel Blends: A Comparison between Benchtop FT-NIR versus a Portable Miniaturized NIR Spectroscopic Analysis
  29. Epigenetic and Drug Response Modulation of Epigalocaten-In-3-Gallate in Staphylococcus aureus with Divergent Resistance Phenotypes
  30. Plasma versus Serum Analysis by FTIR Spectroscopy to Capture the Human Physiological State
  31. Antimicrobial evaluation of the Cynara cardunculus extract in Helicobacter pylori cells using mid-infrared spectroscopy and chemometric methods
  32. Proteomics for Biomarker Discovery for Diagnosis and Prognosis of Kidney Transplantation Rejection
  33. Ovine Model as a Temporomandibular Disc Substitute: Characterisation and the Outcomes of Freezing Storage
  34. Antigenic and conserved peptides from diverse Helicobacter pylori antigens
  35. Infection Biomarkers Based on Metabolomics
  36. Development of a biocompatible hydrogel based on native temporomandibular joint extracellular matrix powder
  37. Fast identification of off‐target liabilities in early antibiotic discovery with Fourier‐transform infrared spectroscopy
  38. A new method to predict genotoxic effects based on serum molecular profile
  39. Technologies for High-Throughput Identification of Antibiotic Mechanism of Action
  40. VARIABILITY OF NEUTROPHIL-ACTIVATING PROTEIN AMONG HELICOBACTER PYLORI STRAINS
  41. Comparison of partial least squares‐discriminant analysis and soft independent modeling of class analogy methods for classification of Saccharomyces cerevisiae cells based on mid‐infrared spectroscopy
  42. Simultaneous elucidation of antibiotic mechanism of action and potency with high-throughput Fourier-transform infrared (FTIR) spectroscopy and machine learning
  43. Potential of FTIR-Spectroscopy for Drugs Screening against Helicobacter pylori
  44. Discriminating B and T-lymphocyte from its molecular profile acquired in a label-free and high-throughput method
  45. FTIR spectroscopy applications for biomedicine
  46. A Simple, Label-Free, and High-Throughput Method to Evaluate the Epigallocatechin-3-Gallate Impact in Plasma Molecular Profile
  47. Metabolic Fingerprinting with Fourier-Transform Infrared (FTIR) Spectroscopy: Towards a High-Throughput Screening Assay for Antibiotic Discovery and Mechanism-of-Action Elucidation
  48. A phenotypic screening bioassay forEscherichia colistress and antibiotic responses based on Fourier‐transform infrared (FTIR) spectroscopy and multivariate analysis
  49. Antibiotic Discovery: Where Have We Come from, Where Do We Go?
  50. Characterization of gastric cells infection by diverse Helicobacter pylori strains through Fourier-transform infrared spectroscopy
  51. Assessing the molecular fingerprint of T lymphocyte activation
  52. Spectral Biomarkers of Genotoxicity from Methanol Extracts of Blood
  53. Impact of the solvent extraction method on the plasma metabolome profile
  54. Classification of recombinant Saccharomyces cerevisiae cells using PLS-DA modelling based on MIR spectroscopy
  55. Effect of culturing human embryos in group on the composition of spent culture media
  56. Towards an automated statistical workflow for biomarker screening in Fourier-transform infrared spectroscopy
  57. Impact of the human mesenchymal stem cells donor on conditional medium composition
  58. Effect of consumption of green tea extracts on the plasma molecular signature
  59. Helicobacter pylori Persistence Throughout the Host Life as a High Risk of Peptic Ulcers, Gastric Cancer and MALT Lymphoma
  60. Determination of Cell Abundances and Paralytic Shellfish Toxins in Cultures of the Dinoflagellate Gymnodinium catenatum by Fourier Transform Near Infrared Spectroscopy
  61. Assessing plasmid bioprocess reproducibility and C-source uptake stage through multivariate analysis of offline and online data
  62. Comparative analysis of different transformed Saccharomyces cerevisiae strains based on high-throughput Fourier transform infrared spectroscopy
  63. High-throughput FTIR-based bioprocess analysis of recombinant cyprosin production
  64. Optimization of a bioassay to evaluate Escherichia coli stress responses
  65. Biopharmaceuticals process monitoring based on infrared spectroscopy according to Quality by Design
  66. High-throughput bioassay for mechanism of action determination of antibacterial drugs
  67. Mid-infrared spectroscopy: A groundbreaking tool for monitoring mammalian cells processes
  68. Does Nonlinear Modeling Play a Role in Plasmid Bioprocess Monitoring Using Fourier Transform Infrared Spectra?
  69. Metabolic profiling of recombinantEscherichia colicultivations based on high-throughput FT-MIR spectroscopic analysis
  70. Monitoring theex-vivoexpansion of human mesenchymal stem/stromal cells in xeno-free microcarrier-based reactor systems by MIR spectroscopy
  71. A comprehensive high-throughput FTIR spectroscopy-based method for evaluating the transfection event: estimating the transfection efficiency and extracting associated metabolic responses
  72. In Situ Near-Infrared (NIR) versus High-Throughput Mid-Infrared (MIR) Spectroscopy to Monitor Biopharmaceutical Production
  73. Molecular fingerprint of human gastric cell line infected by Helicobacter pylori
  74. Development of a high-throughput monitoring technique of bacteria photodynamic inactivation
  75. Process Analytical Technologies in Biopharmaceutical Process Development
  76. In situ near infrared spectroscopy monitoring of cyprosin production by recombinant Saccharomyces cerevisiae strains
  77. Kinetic modeling of plasmid bioproduction in Escherichia coli DH5α cultures over different carbon-source compositions
  78. In situNIR spectroscopy monitoring of plasmid production processes: effect of producing strain, medium composition and the cultivation strategy
  79. Real-time plasmid monitoring of batch and fed-batch Escherichia coli cultures by NIR spectroscopy
  80. High-throughput analysis of the plasmid bioproduction process in Escherichia coli by FTIR spectroscopy
  81. Development and characterization of a new plasmid delivery system based on chitosan–sodium deoxycholate nanoparticles
  82. The importance of Helicobacter pylori's genetic variability for the construction of an efficient vaccine
  83. Modelling, monitoring and control of plasmid bioproduction in Escherichia coli cultures
  84. Protein and DNA nanoparticulate multiantigenic vaccines against H. pylori: In vivo evaluation
  85. A Nonionic Porphyrin as a Noninterfering DNA Antibacterial Agent
  86. Use of chemometrics in the selection of a Saccharomyces cerevisiae expression system for recombinant cyprosin B production
  87. Antigenic Diversity Among Portuguese Clinical Isolates of Helicobacter pylori
  88. Biodegradable nanoparticles of alginate and chitosan as non-viral DNA oral delivery system
  89. Monitoring bacterial processes by Fourier transform infrared spectroscopy: Helicobacter pylori drug inactivation and plasmid bioproduction in recombinant Escherichia coli cultures
  90. Optimization of the culture medium composition using response surface methodology for new recombinant cyprosin B production in bioreactor for cheese production
  91. A novel multifunctional DNA vaccine expresses conserved and immunogenic fragments of six Helicobacter pylori proteins
  92. The carbon-source on the efficiency of plasmid production in high density cultures of Escherichia coli
  93. Influence of tryptophan tags on the purification of cutinase, secreted by a recombinant Saccharomyces cerevisiae, using cationic expanded bed adsorption and hydrophobic interaction chromatography
  94. Prediction of retention time of cutinases tagged with hydrophobic peptides in hydrophobic interaction chromatography
  95. A flow injection analysis system for on‐line monitoring of cutinase activity at outlet of an expanded bed adsorption column almost in real time
  96. Micro-analytical GO/HRP bioreactor for glucose determination and bioprocess monitoring
  97. Integration of the production and the purification processes of cutinase secreted by a recombinant Saccharomyces cerevisiae SU50 strain
  98. Recombinant Saccharomyces cerevisiae strain triggers acetate production to fuel biosynthetic pathways
  99. Pressure-tuning FTIR Spectroscopy: Applications to Biomedical Research and Diagnosis
  100. Towards a cost effective strategy for cutinase production by a recombinant Saccharomyces cerevisiae: strain physiological aspects
  101. Integration of production and aqueous two-phase systems extraction of extracellular cutinase fusion proteins
  102. Development of a Fed-Batch Cultivation Strategy for the Enhanced production and Secretion of Cutinase by a Recombinant Saccharomyces cerevisiae SU50 Strain
  103. Development of a Fed-Batch Cultivation Strategy for the Enhanced Production and Secretion of Cutinase by a Recombinant Saccharomyces cerevisiae SU50 Strain
  104. Effect of Saccharomyces cerevisiae fermentation conditions on expanded bed adsorption of heterologous cutinase
  105. Optimisation of culture conditions and characterisation of cutinase produced by recombinant Saccharomyces cerevisiae
  106. Production of wild-type and peptide fusion cutinases by recombinantSaccharomyces cerevisiae MM01 strains
  107. Effect of pre-fermentation on the production of cutinase by a recombinant Saccharomyces cerevisiae